CST3 and metabolic syndrome: Considering that aging, diabetes, hypertension, metabolic syndrome, and uric nephropathy are major etiologies of CKD [11,12,48,49], cystatin C appears to have important clinical implications for assessing the risk of RKFD in healthy subjects.